ABSTRACT OBJECTIVES This study sought to study the association of atrial fibrillation (AF) with exercise capacity, left ventricular filling pressure, natriuretic peptides, and left atrial size in heart failure with preserved ejection fraction (HFpEF).
fraction (2) . Furthermore, AF has an independent prognostic impact in HFpEF (2) (3) (4) . HFpEF with pulmonary hypertension (10) . Of the 102 patients, 32 (31%) had AF, 62 (61%) had sinus rhythm, and 8 (8%) had paced rhythms during catheterization.
We excluded the 8 patients with paced rhythms from the analyses, leaving 94 patients in the final study population with right heart catheterization. Of these, 90 had simultaneous echocardiography, and 84 had combined left and right heart catheterization. This study was conducted in accordance with local and national regulations regarding retrospective clinical research, and approved by the Institutional Review Board of the University Medical Center Groningen.
STUDY PROCEDURES. Detailed study procedures have been previously published (10) . In brief, patients underwent standardized clinical evaluation and 12-lead electrocardiography at rest. Treadmill exercise cardiopulmonary oxygen gas exchange was performed, with peak oxygen consumption (VO 2 ) determined at maximal exertion (when the patient either reached a plateau phase for 1 minute, could not walk further, was unable to maintain walking speed, or displayed a reduction in breathing reserve and oxygen heart rate).
Cardiac catheterization with simultaneous echocardiography was performed under stable, fasting conditions with the patient in supine position. All echocardiograms were measured by the same investigator (YMH), and all cardiac catheterizations were performed by the same cardiologist (ESH). Intraobserver reproducibility for standard echo measurements was evaluated in a subset of 20 randomly selected examinations and showed excellent reproducibility (correlation >0.8 for all 2-dimensional and Doppler parameters). During cardiac catheterization, a 7-F thermodilution balloon-tipped catheter was inserted into the right femoral vein, floated under fluoroscopy to the right atrium, advanced to the right ventricle, and positioned in the pulmonary artery. Change from the pulmonary artery waveform to the typical pulmonary wedge pressure waveform on inflation of the balloon catheter and the expected fluoroscopic position of the catheter were ensured for satisfactory pulmonary wedge pressure determination. PCWP was measured at end-expiration and used as a surrogate measure of the LVEDP as previously validated (11) . Left heart catheterization was performed to exclude significant coronary artery disease or left-sided valve disease, and LVEDP was measured. All hemodynamic measurements were performed before contrast injections.
Simultaneous echocardiographic image acquisition was performed according to a pre-specified protocol using a Vivid S6 (GE, Horton, Norway) and a 2. 
AF in HFpEF -2 0 1 6 : ---2 using the biplane areaÀlength method. All measurements were determined using the average of at least 3 cardiac cycles in patients with AF.
Blood draw was performed at baseline for measurements of NT-proBNP by the Elecsys proBNP enzyme-linked immunosorbent assay (Roche Diagnostics, Mannheim, Germany). The assay has a lower detection limit of 5.00 pg/ml and an analytical variability of 3.3% in our laboratory. Figure 1A ). Median (25th, 75th percentile) NT-proBNP was markedly higher in the AF group compared with those in sinus rhythm (1,689; 851 to 2,637 pg/ml vs. 490; 272 to 1,019 pg/ml; p < 0.0001) ( Figure 1B) .
ECHOCARDIOGRAPHIC CHARACTERISTICS. According to the echocardiograms ( Table 2) , there were no statistically significant differences in LV ejection fraction, Values are mean AE SD, n (%), or median (interquartile range).
ACEI ¼ angiotensin-converting-enzyme inhibitor; AF ¼ atrial fibrillation; ARB ¼ angiotensin receptor blocker; eGFR ¼ estimated glomerular filtration rate; NT-proBNP ¼ N-terminal proÀB-type natriuretic peptide; NYHA ¼ New York Heart Association; VO2 ¼ oxygen consumption.
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AF in HFpEF AF ¼ atrial fibrillation; TAPSE ¼ tricuspid annular plane systolic excursion.
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The RELAX investigators also found similar E/e Table 1 .
HFpEF without pulmonary hypertension. We did not include controls without HFpEF. The cross-sectional design precluded definite conclusions about causeeffect relationships. Although all patients had right heart catheterization and echocardiography, not all had combined left and right heart catheterization.
However, left-sided invasive measurements were available in most of the patients (89%), and our study provided the first data on invasive hemodynamic correlates of AF in HFpEF combined with simultaneous comprehensive Doppler echocardiography. No information on duration of AF history or current episode was available, nor was detailed information on heart rate control (resting and exercise) available.
Repeat measurements pre-and post-exercise or preand post-cardioversion would have been informative, but were not available in our study. These represent areas for future study.
CONCLUSIONS
HFpEF with AF is associated with greater exertional intolerance, pulmonary venous congestion, natriuretic peptide elevation, and left atrial remodeling compared with those in sinus rhythm. 
